✦ LIBER ✦

Treatment persistence, hypoglycaemia and clinical outcomes in type 2 diabetes patients with dipeptidyl peptidase-4 inhibitors and sulphonylureas: a primary care database analysis

✍ Scribed by W. Rathmann; K. Kostev; J. B. Gruenberger; M. Dworak; G. Bader; G. Giani

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dipeptidyl peptidase-4 inhibitors for tr

📂 Article 📅 2012 🏛 BMJ Publishing Group 🌐 English ⚖ 137 KB

Dipeptidyl peptidase-4 inhibitors for tr

📂 Article 📅 2012 🏛 BMJ Publishing Group 🌐 English ⚖ 135 KB

Clinical and economical consequences of

✍ Sicras Mainar, A.; Roldán Suárez, C.; Font Ramos, B.; Navarro Artieda, R.; Ibáñe 📂 Article 📅 2013 🏛 Elsevier ⚖ 517 KB

Longer term safety of dipeptidyl peptida

✍ K. Gooßen; S. Gräber 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 726 KB

Treatment of elderly patients with type

✍ Sherwyn L. Schwartz 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Efficacy, safety and dose-response relat

✍ Kadowaki, T.; Kondo, K. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 649 KB